Titre : | Hepatitis C in methadone maintenance patients: prevalence and public policy implications |
Titre traduit : | (L'hépatite C chez les patients en traitement de maintenance à la méthadone : prévalence et implications pour les politiques publiques.) |
Auteurs : | J. J. McCARTHY ; N. FLYNN |
Type de document : | Périodique |
Année de publication : | 2001 |
Format : | 19-31 / tabl. |
Note générale : |
Journal of Addictive Diseases, 2001, 20, (1), 19-31 |
Langues: | Anglais |
Discipline : | MAL (Maladies infectieuses / Infectious diseases) |
Mots-clés : |
Thésaurus mots-clés HEPATITE ; INFECTION ; PREVALENCE ; EPIDEMIOLOGIE DESCRIPTIVE ; INJECTION ; POPULATION A RISQUE |
Résumé : |
ENGLISH : Objective: This study measured the extent and examined implications of hepatitis C (HCV) infection in a methadone maintenance treatment (MMT) population. Method: Four hundred and sixty patients were tested for HCV-Ab, hepatic enzymes and bilirubin, HCV-RNA, and hepatitis B antibody. Results: Overall, 87% of this population had evidence of HCV-Ab. Among drug injectors (IDU), 96% were HCV-Ab positive. Among a subset of Laotian opium-smoking patients prevalence was only 11%. Sixty-two percent of patients with HCV-Ab had detectable HCV-RNA. Only 41 % had elevated hepatic enzymes, and 5% had elevated bilirubin levels. All age groups were equally infected. Systemic problems in screening and treating HCV in drug users were identified. Conclusion: HCV infection poses significant long-term health risks for this population. Harm reduction interventions aimed at reducing transmission of HCV and other needle-related infectious disease deserves more consideration. (Author' s abstract) |
Note de contenu : | tabl. |
Domaine : | Drogues illicites / Illicit drugs |
Refs biblio. : | 33 |
Affiliation : |
2100 Capitol Ave, Sacramento, CA 95816 Etats-Unis. United States. |
Numéro Toxibase : | 205651 |
Centre Emetteur : | 02 Coordonnateur |
Exemplaires
Disponibilité |
---|
aucun exemplaire |
Accueil